Pseudovirus & Virus-Like Particle Production
Pseudovirus and Virus-Like Particle Production | eEnzyme
eEnzyme produces replication-deficient pseudotyped viral particles that display selected viral envelope or surface glycoproteins. These particles provide practical research tools for studying viral entry, receptor interactions, antibody neutralization, vaccine responses, and antiviral candidates without using replication-competent target viruses.
|
MLV-Based Particles
Replication-deficient MLV-based pseudoviruses for selected enveloped-virus glycoproteins.
|
Lentiviral Platforms
Lentivirus-based pseudotyped particles for compatible viral targets and reporter applications.
|
Custom Strains & Variants
Custom surface proteins, strains, or variants can be evaluated when not available as catalog items.
|
Production Capabilities
|
Target Design
Selection and cloning of viral envelope or surface proteins, including project-specific variants and sequence modifications.
|
Particle Production
Transient production using appropriate packaging, reporter, and glycoprotein-expression components.
|
|
Available Viral Targets
Current experience includes coronavirus, influenza, hantavirus, and other enveloped-virus systems.
|
Characterization
Project-specific evaluation may include reporter activity, infectivity, target-cell entry, antigen expression, or particle-associated analyses.
|
Research Applications
|
• Viral entry and receptor-interaction studies
• Neutralizing-antibody evaluation
• Vaccine-response research
|
• Antiviral-compound screening
• Variant comparison
• Target-cell validation
|
Discuss a Custom Pseudovirus
Send the virus, strain or variant, surface protein, reporter preference, and intended application for project evaluation.
Email info@eEnzyme.com
|
|
|